Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BLAC
BLAC logo

BLAC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
43.48M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
8.75M
EV/OCF(TTM)
--
P/S(TTM)
--
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.
Show More

Events Timeline

No data

No data

News

Business Insider
2.0
2025-02-14Business Insider
Bellevue Life Sciences Acquisition Corp trading resumes
  • Trading Resumption: Bellevue Life Sciences Acquisition Corp (BLAC) has resumed trading after a previous halt due to volatility.

  • Investment Insights: TipRanks offers a Smart Score tool to help investors identify top-performing stocks and compare their picks with Wall Street analysts' recommendations.

Business Insider
2.0
2025-02-14Business Insider
Bellevue Life Sciences Acquisition Corp trading halted, volatility trading pause
  • Trading Halt: Bellevue Life Sciences Acquisition Corp (BLAC) experienced a trading halt due to volatility, indicating significant fluctuations in its stock price.

  • Investment Insights: TipRanks offers a Smart Score tool that helps investors identify top-performing stocks and compare their picks with recommendations from leading Wall Street analysts.

Benzinga
4.5
2025-02-14Benzinga
US Stocks Edge Higher; Deere Posts Upbeat Earnings
  • U.S. Stock Market Performance: U.S. stocks saw slight gains with the S&P 500 up by 0.1%, while energy shares rose by 1.5%. However, retail sales fell by 0.9% in January, exceeding market expectations of a smaller decline.

  • Global Market Trends: European shares were mixed, with the eurozone's STOXX 600 down 0.1%, and Asian markets closed mixed as well, with Japan's Nikkei 225 falling 0.79% and China's Shanghai Composite gaining 0.43%.

Benzinga
4.5
2025-02-14Benzinga
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'
  • Market Overview: U.S. stock futures showed little movement after a recent rally, with investors reacting to President Trump's tariff announcements that may not take effect immediately, while the Federal Reserve is expected to maintain interest rates unchanged for March.

  • Stock Performance Highlights: Major indices saw gains on Thursday, led by sectors like materials and technology; notable individual stock movements included Airbnb's significant rise post-earnings and declines for Mynaric AG following a delisting notification.

Benzinga
9.5
2025-02-14Benzinga
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
  • Airbnb Financial Results: Airbnb's shares surged 13.9% in pre-market trading after reporting fourth-quarter revenue of $2.5 billion, exceeding analyst expectations and marking a 12% year-over-year increase driven by growth in nights stayed and average daily rates.

  • Stock Movements: Several stocks experienced significant pre-market movements, with Virpax Pharmaceuticals gaining 78.4% following positive study results, while others like PicoCELA and Mynaric saw substantial declines of 54.6% and 39%, respectively, due to negative news or performance.

PRnewswire
6.4
2024-07-18PRnewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FRLA, BLAC, SLAM on Behalf of Shareholders
  • Investigation of Companies: Halper Sadeh LLC is investigating Fortune Rise Acquisition Corporation, Bellevue Life Sciences Acquisition Corp., and Slam Corp. for potential violations of federal securities laws and breaches of fiduciary duties related to their respective mergers.

  • Shareholder Rights: The law firm encourages shareholders from these companies to contact them for free consultations regarding their legal rights and options, emphasizing that they operate on a contingent fee basis.

Wall Street analysts forecast BLAC stock price to rise
0 Analyst Rating
Wall Street analysts forecast BLAC stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Bellevue Life Sciences Acquisition Corp (BLAC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Bellevue Life Sciences Acquisition Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding BLAC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Bellevue Life Sciences Acquisition Corp (BLAC) stock price today?

The current price of BLAC is 0 USD — it has increased 0

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s business?

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

What is the price predicton of BLAC Stock?

Wall Street analysts forecast BLAC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLAC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s revenue for the last quarter?

Bellevue Life Sciences Acquisition Corp revenue for the last quarter amounts to -454.13K USD, increased 10.65

What is Bellevue Life Sciences Acquisition Corp (BLAC)'s earnings per share (EPS) for the last quarter?

Bellevue Life Sciences Acquisition Corp. EPS for the last quarter amounts to -226880.00 USD, increased 58.41

How many employees does Bellevue Life Sciences Acquisition Corp (BLAC). have?

Bellevue Life Sciences Acquisition Corp (BLAC) has 0 emplpoyees as of April 04 2026.

What is Bellevue Life Sciences Acquisition Corp (BLAC) market cap?

Today BLAC has the market capitalization of 43.48M USD.